There exists no company with greater apathy, indifference, and exploitation toward sales professionals within their contract sales operations.
For starters, no IQVIA employee will earn more than their client organization counterpart. For example, a clinical sales position of Company X contracting with IQVIA invariable earns 1.25 to 2 times what the IQVIA representative will. Further, incentive earnings are typically a fraction of what direct client counterparts will earn. The only exception are those earnings by the smallest percentage (often top 2%) with the greatest performance.
Morale among current representatives of current contracts could not be lower than it is now. IQVIA exploits the current flux and instability of sales operations within most pharmaceutical companies. It leverages this circumstance, in part, with direct and indirect intimidation to prevent employees from demanding parity and speaking out for fear of their jobs.
IQVIA has regrettably deviated from its initial charge of partnering and advancing the operations of other biotech and pharmaceutical organizations. It now operates largely as a 'temp agency' providing highly qualified professionals in highly competitive markets at 'low rent' compensation, whereby the client organization has no obligation to employees. Further, all incentive earnings go directly to IQVIA where only the highest performing territories are compensated, leaving the 'lower 90%' at a percentage of what their client counterparts earn.
Current industry dynamics and shifting stability (e.g. layoffs, downsizing, realignments, etc.) within pharmaceuticals sales leave many sales professionals at the mercy of such operations. In fairness, Inventive, Publicis, et al operate similarly.
Until IQVIA contract-sales professionals (and others) assert their intrinsic and professional value, holding IQVIA squarely accountable, sadly, nothing will change. In fact, it will invariably worsen. And to those who readily proclaim, "...if you don't like it, get another job," I say examine your own circumstance. No, really. Examine your own circumstance; your own innate and intrinsic value to your organization. Are you content existing as only a commodity? Are you fulfilled knowing your organization places you upon the 'liability' side of the ledger? Have you no stake in the success of your company--most importantly the patients you advocate on behalf of?
Sadly, IQVIA has evolved, in truth 'devolved' into the Micky D's of Pharma. The immediate satisfaction of cheap, savory fare is rarely filling, always fleeting and inevitably at a far greater cost than any 'dollar menu.
IQVIA = BEWARE
For starters, no IQVIA employee will earn more than their client organization counterpart. For example, a clinical sales position of Company X contracting with IQVIA invariable earns 1.25 to 2 times what the IQVIA representative will. Further, incentive earnings are typically a fraction of what direct client counterparts will earn. The only exception are those earnings by the smallest percentage (often top 2%) with the greatest performance.
Morale among current representatives of current contracts could not be lower than it is now. IQVIA exploits the current flux and instability of sales operations within most pharmaceutical companies. It leverages this circumstance, in part, with direct and indirect intimidation to prevent employees from demanding parity and speaking out for fear of their jobs.
IQVIA has regrettably deviated from its initial charge of partnering and advancing the operations of other biotech and pharmaceutical organizations. It now operates largely as a 'temp agency' providing highly qualified professionals in highly competitive markets at 'low rent' compensation, whereby the client organization has no obligation to employees. Further, all incentive earnings go directly to IQVIA where only the highest performing territories are compensated, leaving the 'lower 90%' at a percentage of what their client counterparts earn.
Current industry dynamics and shifting stability (e.g. layoffs, downsizing, realignments, etc.) within pharmaceuticals sales leave many sales professionals at the mercy of such operations. In fairness, Inventive, Publicis, et al operate similarly.
Until IQVIA contract-sales professionals (and others) assert their intrinsic and professional value, holding IQVIA squarely accountable, sadly, nothing will change. In fact, it will invariably worsen. And to those who readily proclaim, "...if you don't like it, get another job," I say examine your own circumstance. No, really. Examine your own circumstance; your own innate and intrinsic value to your organization. Are you content existing as only a commodity? Are you fulfilled knowing your organization places you upon the 'liability' side of the ledger? Have you no stake in the success of your company--most importantly the patients you advocate on behalf of?
Sadly, IQVIA has evolved, in truth 'devolved' into the Micky D's of Pharma. The immediate satisfaction of cheap, savory fare is rarely filling, always fleeting and inevitably at a far greater cost than any 'dollar menu.
IQVIA = BEWARE